Inhibition of histone deacetylase activity by butyrate
- PMID: 12840228
- DOI: 10.1093/jn/133.7.2485S
Inhibition of histone deacetylase activity by butyrate
Abstract
This article reviews the effects of the short-chain fatty acid butyrate on histone deacetylase (HDAC) activity. Sodium butyrate has multiple effects on cultured mammalian cells that include inhibition of proliferation, induction of differentiation and induction or repression of gene expression. The observation that butyrate treatment of cells results in histone hyperacetylation initiated a flurry of activity that led to the discovery that butyrate inhibits HDAC activity. Butyrate has been an essential agent for determining the role of histone acetylation in chromatin structure and function. Interestingly, inhibition of HDAC activity affects the expression of only 2% of mammalian genes. Promoters of butyrate-responsive genes have butyrate response elements, and the action of butyrate is often mediated through Sp1/Sp3 binding sites (e.g., p21(Waf1/Cip1)). We demonstrated that Sp1 and Sp3 recruit HDAC1 and HDAC2, with the latter being phosphorylated by protein kinase CK2. A model is proposed in which inhibition of Sp1/Sp3-associated HDAC activity leads to histone hyperacetylation and transcriptional activation of the p21(Waf1/Cip1) gene; p21(Waf1/Cip1) inhibits cyclin-dependent kinase 2 activity and thereby arrests cell cycling. Pending the cell background, the nonproliferating cells may enter differentiation or apoptotic pathways. The potential of butyrate and HDAC inhibitors in the prevention and treatment of cancer is presented.
Similar articles
-
p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.Oncol Rep. 2005 Jun;13(6):1139-44. Oncol Rep. 2005. PMID: 15870934
-
Histone deacetylase inhibitors decrease proliferation and modulate cell cycle gene expression in normal mammary epithelial cells.Clin Cancer Res. 2000 Nov;6(11):4334-42. Clin Cancer Res. 2000. PMID: 11106251
-
The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene.Mol Cell Biol. 2003 Apr;23(8):2669-79. doi: 10.1128/MCB.23.8.2669-2679.2003. Mol Cell Biol. 2003. PMID: 12665570 Free PMC article.
-
Histone deacetylase inhibitors: signalling towards p21cip1/waf1.Int J Biochem Cell Biol. 2007;39(7-8):1367-74. doi: 10.1016/j.biocel.2007.03.001. Epub 2007 Mar 7. Int J Biochem Cell Biol. 2007. PMID: 17412634 Review.
-
Histone deacetylase inhibitor activates the p21/WAF1/Cip1 gene promoter through the Sp1 sites.Ann N Y Acad Sci. 1999;886:195-9. doi: 10.1111/j.1749-6632.1999.tb09415.x. Ann N Y Acad Sci. 1999. PMID: 10667218 Review.
Cited by
-
Interplay of Good Bacteria and Central Nervous System: Cognitive Aspects and Mechanistic Considerations.Front Neurosci. 2021 Feb 11;15:613120. doi: 10.3389/fnins.2021.613120. eCollection 2021. Front Neurosci. 2021. PMID: 33642976 Free PMC article. Review.
-
Microbiota-derived short chain fatty acids modulate microglia and promote Aβ plaque deposition.Elife. 2021 Apr 13;10:e59826. doi: 10.7554/eLife.59826. Elife. 2021. PMID: 33845942 Free PMC article.
-
Autism spectrum disorders and intestinal microbiota.Gut Microbes. 2015;6(3):207-13. doi: 10.1080/19490976.2015.1035855. Gut Microbes. 2015. PMID: 25835343 Free PMC article. Review.
-
Metabolic regulation of histone post-translational modifications.ACS Chem Biol. 2015 Jan 16;10(1):95-108. doi: 10.1021/cb500846u. ACS Chem Biol. 2015. PMID: 25562692 Free PMC article. Review.
-
Unravelling lactate-acetate and sugar conversion into butyrate by intestinal Anaerobutyricum and Anaerostipes species by comparative proteogenomics.Environ Microbiol. 2020 Nov;22(11):4863-4875. doi: 10.1111/1462-2920.15269. Epub 2020 Oct 12. Environ Microbiol. 2020. PMID: 33001550 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous